摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[o-(Ph2PCH2P(Ph)2N)C6H4N(CH)2N(CH2Ph)CH]Br | 1196117-31-3

中文名称
——
中文别名
——
英文名称
[o-(Ph2PCH2P(Ph)2N)C6H4N(CH)2N(CH2Ph)CH]Br
英文别名
——
[o-(Ph2PCH2P(Ph)2N)C6H4N(CH)2N(CH2Ph)CH]Br化学式
CAS
1196117-31-3
化学式
Br*C41H36N3P2
mdl
——
分子量
712.608
InChiKey
DRANEEKHGGBAHX-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.39
  • 重原子数:
    47.0
  • 可旋转键数:
    10.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    21.17
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and characterization of zinc complexes supported by NHC-based CNN- and CNP-tridentate ligands and their catalysis in the ring-opening polymerization of rac-lactide and ε-caprolactone
    摘要:
    A series of zinc complexes bearing NHC-based C,N,N- or C,N,P-tridentate ligands were synthesized and characterized and the catalysis of the complexes toward the ring-opening polymerization of rac-lactide was evaluated. The ligand precursors [2-(CHN(R)(CH)(2)N)C6H4N=P(Pb)(2)CH2(Ph)(2)CH2Py](+) I- (2a, R = Me; 2b, R = iPr) prepared from [2-N3C6H4(N(CH)(2)N(R)CH)](+) I- (R = Me or iPr) and Ph2PCH2Py were successively treated with nBuLi and ZnEt2 to afford corresponding zinc complexes [Zn(Et){2-(CN(R)(CH)(2)N)(C6H4NP(Ph)(2)=CHpy}] (3a, R = Me; 3b, R = iPr). Similar treatment of [2-(CHN(Me)(CH)(2)N)C6H4N P(Ph)(2)CH2PPh2]I-+(-) (4a) (prepared from [2-N3C6H4(N(CH)(2)N(Me)CH)(+) I- and Ph2PCH2PPh2) with nBuLi and then ZnEt2 gave [Zn(Et){2-(CN(Me)(CH)(2)N)C6H4NP(Ph)(2)=CHPPh2)] (5). Treatment of [2-(CHN(R)(CH2N)C6H4N-P(Ph)(2)CH2PPh2]X-+(-) (4a, R = Me, X = l; 4h, R = Bn, X = Br; 4c, R = iPr, X = l) with p-MeC6H4N3 resulted in [2-(CHN(R)(CH)(2)N)C6H4N P(Ph)(2)CH2F(Ph)(2)=N(p-MeC6H4)(+) X-(6a, R = Me, X = l; 6b, R = Bn, X = Br; 6c, R = iPr, X = l). The reaction of 6a with nBuLi and ZnEt2 in sequence produced IZn(Et){2-(CN(Me)(CH)(2)N)C6H4NP(Ph)(2)=C1IP(Ph)(2)=N(p-McC(6)H(4))}1 (7). Whereas the reaction of 6a c with an equimolar amount of ZnEt2 gave [Zn(X){2-(ON(R)(CH)(2))C6H4NP(Ph)(2)=CHP(Ph)(2)=N(p-MeC6H4)}1(8a, R = Me, X = l; 8b, R = Bn, X = Br; 8c, R = iPr, X = l). All new compounds were characterized by H-1, C-13 and P-31 NMR spectroscopy and elemental analyses. The structures of complexes 3a, 5 and 8b were additionally characterized by single crystal X-ray diffraction. In the presence of BnOH complexes 3a, 3b, 5 and 7 catalyze the ring-opening polymerization of rac-lactide at room temperature and 3a, 3b, and 5 exhibited high activity. Complexes 8a c are inactive under the same conditions. Complexes 3a and 5 were also tested for the catalysis in the ROP of epsilon-caprolactone and both showed good catalytic activity. (C) 2015 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2015.02.013
点击查看最新优质反应信息

文献信息

  • N-Heterocyclic Carbene-Based Nickel Complexes: Synthesis and Catalysis in Cross-Couplings of Aryl Chlorides with ArMX (M = Mg or Zn)
    作者:Cheng Zhang、Zhong-Xia Wang
    DOI:10.1021/om9006399
    日期:2009.11.23
    LiBun. C,N,P-Chelate nickel complex [Ni(Br)2-(CN(CH2Ph)(CH)2N)C6H4N═P(Ph2)CH2PPh2}]+Br− was obtained by a similar reaction between (DME)NiBr2 and 2-(CN(CH2Ph)(CH)2N)C6H4N═P(Ph2)CH2PPh2 ligand prepared from the imidazolium salt and 1 equiv of LiBun. Tetradentate chelate nickel complex [Ni2-(CN(CH2Ph)(CH)2N)C6H4N═P(Ph2)}2CH]+Cl− was synthesized by transmetalation between (DME)NiCl2 and [Li2-(CN(CH2P
    两个C,N,N -螯合物络合物,[(Cl)的2-(CN(ME)(CH)2 N)C号6 ħ 4 N = P(PH 2)CH 2比利牛斯}] +我-和[(Cl)的2-(CN(我)(CH)2 N)C号6 ħ 4 N = P(PH 2)CH 2 P(博士2)= NC 6 H ^ 4 ME-4}] +我-通过(DME)NiCl 2(DME = 1,2-二甲氧基乙烷)与2-(CN(R)(CH)2 N)C 6 H 4反应合成N = P(PH 2)CH 2 Z(R = Me中,Z = 2-比利牛斯; R = PR我,Z = p -MeC 6 ħ 4 N = P(PH 2))配体,其制备在原位由对应咪唑鎓盐与礼部的1个当量的反应ñ。C,N,P螯合物络合物[(BR)2-(CN(CH 2 PH)(CH)2 N)C号6 ħ 4 N = P(PH 2)CH 2 PPH 2 }] +-通过(DME)NiBr
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫